GB Sciences, Inc.
GBLX
$0.0002
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.80% | -37.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.80% | -37.90% | |||
| Operating Income | 57.79% | 37.90% | |||
| Income Before Tax | 47.30% | 33.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 47.30% | 33.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 47.30% | 33.16% | |||
| EBIT | 57.79% | 37.90% | |||
| EBITDA | 57.87% | 37.95% | |||
| EPS Basic | 60.00% | 28.57% | |||
| Normalized Basic EPS | 33.33% | 25.00% | |||
| EPS Diluted | 60.00% | 28.57% | |||
| Normalized Diluted EPS | 33.33% | 25.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.12% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||